A 3-D printed home could be built in 48 hours for only $10,000. Photo courtesy of ICON Build

In the not-too-distant future, a Texas company's 3-D printed homes will be popping up across the world for a fraction of the cost of traditional homes.

"It's our mission at ICON to reimagine the approach to homebuilding and construction and make affordable, dignified housing available to everyone throughout the world," says Jason Ballard, co-founder and CEO of Austin-based ICON LLC. "We're in the middle of a global housing crisis, and making old approaches a little better is not solving the problem."

The 3-D printed homes startup just raked in $9 million in seed funding from a host of investors, including Fort Worth-based homebuilding giant D.R. Horton; Vulcan Capital, a Seattle investment firm launched by Microsoft billionaire Paul Allen, who died October 15; Austin startup accelerator Capital Factory; Austin real estate developer Cielo Property Group; and San Francisco venture capital firm Oakhouse Partners, which is the lead investor.

At this point, ICON executives aren't sure when their homes will be popping up around town. However, Ballard tells CultureMap, "serious conversations" are underway about bringing these homes to Austin and other places around the world.

In March, ICON reaped tons of press when it unveiled a 350-square-foot 3-D home at SXSW — the first home of its kind to receive a construction permit in the U.S. At the time, ICON executives said the home — constructed of concrete and printed in less than 48 hours by 3-D printing robots — cost less than $10,000. By contrast, the median price in September 2018 of a single-family home in the Austin metro area was $302,250.

ICON's first batch of homes is planned for a project in impoverished El Salvador that's being developed in conjunction with New Story, a San Francisco nonprofit that seeks to eradicate homelessness. The first homes there are scheduled to be printed next year.

ICON is targeting a per-home cost of $4,000 in El Salvador. Relying on technology upgrades, ICON hopes to create each 3-D home in less than 24 hours.

"While prices to print homes will vary from country to country and state to state," Ballard says, "the big takeaway is that downloading and printing a home has the potential to cost half of standard construction costs."

Homes at the development in El Salvador will measure 600 to 800 square feet — around the size of a typical one-bedroom apartment. Eventually, ICON aims to print homes in the 1,500- to 2,000-square-foot range.

Among the advantages of 3-D printed homes cited by ICON are:

  • Speedy construction
  • No manual labor
  • Little generation of leftover construction materials
  • "Tremendous" design freedom

There's a positive environmental impact with this construction process as well.

"Conventional construction is slow, fragmented, wasteful, and has poor thermal properties that increase energy use, increase operating costs, and decrease comfort," Ballard says. "Also, conventional materials like drywall and particleboard are some of the least resilient materials ever invented."

---

This story originally appeared on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.